KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Net Cash Flow (2016 - 2025)

Astrana Health (ASTH) has disclosed Net Cash Flow for 16 consecutive years, with -$30.3 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 49.14% to -$30.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $144.9 million through Dec 2025, up 2969.61% year-over-year, with the annual reading at $144.9 million for FY2025, 2969.61% up from the prior year.
  • Net Cash Flow hit -$30.3 million in Q4 2025 for Astrana Health, down from $124.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $124.0 million in Q3 2025 to a low of -$59.5 million in Q4 2024.
  • Historically, Net Cash Flow has averaged $12.0 million across 5 years, with a median of $8.4 million in 2021.
  • Biggest five-year swings in Net Cash Flow: crashed 399.7% in 2024 and later soared 955.93% in 2025.
  • Year by year, Net Cash Flow stood at $28.3 million in 2021, then surged by 267.15% to $104.0 million in 2022, then tumbled by 80.9% to $19.9 million in 2023, then crashed by 399.7% to -$59.5 million in 2024, then soared by 49.14% to -$30.3 million in 2025.
  • Business Quant data shows Net Cash Flow for ASTH at -$30.3 million in Q4 2025, $124.0 million in Q3 2025, and $81.2 million in Q2 2025.